1、Driving resiliency2024 Global Life Sciences Sector Outlook2ContentsIntroduction 3Value creation:M&A,partnerships,collaborations,new sources of capital,and shifting portfolios 5Extracting value from Generative AI and emerging technologies 17Pricing pressures rising globally,threats of impacts on R&D

2、innovation worldwide 31Accelerating speed of time to value in R&D 48Shifting trends in openness:Globalization vs.localization and impacts for multinational companies 60Achieving better patient outcomes with personalized experiences and shared decision-making 75Contacts 90Learn more 92Endnotes 943Int

3、roductionIntroductionWith the global pandemic firmly in the rearview mirror,life sciences companies are looking at key macro-and micro-economic drivers to guide their future growth.While the list of trends with wide-ranging global impact is broad,in this year,life sciences enterprises are paying par

4、ticular attention to those more disruptive trends including increasing pricing pressures and changes in United States regulation,the acceleration of Generative AI(GenAI)adoption and impact,the geo-political environment,and as always,breakthrough science and outcomes.Companies are exploring how the e

5、volution of GenAI can impact their operations and determining where to focus first and how to generate differential value.The potential of advanced technologies and these collaborations are directly integrated with life sciences companies overall efforts to improve patient outcomes and inform their

6、R&D decisions.Companies are looking to the potential of GenAI to bring more value across the boardboth in terms of cost reduction and revenue uplift.GenAI and other AI technologies,coupled with digital transformation tools,are poised to increase overall efficiencies and process innovation across man